References
- Liampas A, Parperis K, Erotocritou MF, Nteveros A, Papadopoulou M, Moschovos C, Akil M, Coaccioli S, Hadjigeorgiou GM, Hadjivassiliou M, Zis P. Primary Sjögren syndrome-related peripheral neuropathy: A systematic review and meta-analysis. Eur J Neurol. 2023 Jan;30(1):255–265. DOI: 10.1111/ene.15555. Epub 2022 Sep 23. PMID: 36086910. PMCID: PMC10087501.
- Molina JA, Benito-León J, Bermejo F, Jiménez-Jiménez FJ, Oliván J. Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjögren’s syndrome. J Neurol Neurosurg Psychiatry. 1996;60(6):
699 . DOI: 10.1136/jnnp.60.6.699 - Pereira PR, Viala K, Maisonobe T, Haroche J, Mathian A, Hié M, et al.
Sjögren sensory neuronopathy (Sjögren ganglionopathy): long-term outcome and treatment response in a series of 13 cases . Medicine (Baltimore). 2016;95(19):e3632 . DOI: 10.1097/MD.0000000000003632 - Khan S, Khan MF, Javed A, Saeed MA, Rehman A.
Autoimmune sensory ganglionopathy in primary Sjögren’s syndrome treated with combination therapy of cyclophosphamide and rituximab: a case report . Neuropsychiatry (Lond). 2019. 9(5):2073–2076. DOI: 10.4172/Neuropsychiatry.1000551